London: Scientists have identified a small neutralising antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells. It has the potential to be developed as an antiviral treatment against COVID-19, reported ZeeNews quoting an IANS report.
The study was published in the journal Nature Communications.
“We hope our findings can contribute to the amelioration of the Covid-19 pandemic by encouraging further examination of this nanobody as a therapeutic candidate against this viral infection,” study co-author Gerald McInerney from the Karolinska Institute in Sweden was quoted as saying.
According to the researchers, nanobodies offer several advantages over conventional antibodies as candidates for specific therapies.
They span less than one-tenth the size of conventional antibodies and are typically easier to produce cost-effectively at scale, the report added.
Critically, they can be adapted for humans with current protocols and have a proven record of inhibiting viral respiratory infections, ZeeNews added.
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…